Target intelligence / Profile preview

Gastric and esophageal mucosal surface

Molecular classification
Other
01

Overview

The gastric and esophageal mucosal surface is the innermost tissue layer of the upper gastrointestinal tract, serving as a vital physiological barrier against aggressive luminal factors such as hydrochloric acid, pepsin, and bile salts (StatPearls, 2023). This surface is characterized by a complex defense system including a mucus-bicarbonate layer, tight junctions between epithelial cells, and a rich submucosal blood flow that facilitates rapid cellular repair (NCBI, 2022). In the esophagus, the mucosa is primarily composed of stratified squamous epithelium for mechanical durability, whereas the gastric mucosa is specialized for secretion and acid resistance (PubMed, 2021). Impairment of this mucosal integrity is a primary driver in the development of erosive esophagitis, peptic ulcers, and chronic inflammatory states like gastritis (NIH, 2023). While not a single molecular target like a receptor or enzyme, it is the site of action for cytoprotective agents and mucosal adherents that reinforce the barrier to promote healing and prevent further injury (PubChem, 2024).

Other names
Gastric mucosaEsophageal mucosaGastroesophageal liningGastric mucosal barrierEsophageal mucosal barrier
02

Mechanism of action

Drugs interacting with this surface typically function by forming a physical protective layer (polymeric film), neutralizing luminal acid, or stimulating the secretion of endogenous cytoprotective factors such as mucus, bicarbonate, and prostaglandins (StatPearls, 2023; PubChem, 2024).

03

Biological functions

Barrier functionCytoprotectionSecretory functionAcid-base regulationMechanical protection
04

Disease associations

Gastroesophageal reflux disease (GERD)Peptic ulcer diseaseGastritisBarrett's esophagusEsophageal cancerGastric cancer
05

Safety considerations

Aluminum accumulation in patients with renal impairment (sucralfate)Masking of symptoms of underlying gastric malignancyDrug-drug interactions due to altered absorptionConstipation
06

Interacting drugs

Sucralfate

5 more in the full profile.

07

Biomarkers

Endoscopic mucosal appearanceMucosal impedancePepsinogen I/II ratioGastrin-17Mucosal pH

Beyond the preview

Go deeper on Gastric and esophageal mucosal surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric and esophageal mucosal surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call